Riskpilot← Back to searchSign inGet full accessFlexident Holding AB
ABActiveOrg 5591185995Gårdsfogdevägen 18 AWholesale of pharmaceutical and medical goods · NACE 4646Est. 20170 employees
Revenue 2024
SEK 95K
+2275% vs 2023
EBITDA margin
-1886.3%
+71% vs 2023
Equity ratio
96.8%
Financial strength
Net profit 2024
SEK 4,2M
-46% vs 2023
| Revenue | SEK 95K | +2275% |
| EBITDA | SEK -1,8M | +71% |
| Net profit | SEK 4,2M | -46% |
| Total assets | SEK 26,9M | -6% |
| Equity | SEK 26M | -6% |
| Employees | 0 | — |
Legal name
Flexident Holding AB
Org number
5591185995
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6 juli 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Företaget ska bedriva partihandel med medicinsk utrustning och apoteksvaror samt äga och förvalta värdepapper.
Address
Gårdsfogdevägen 18 A
Email
robeirsaliba@flexident.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 48 379 | 16 497 | 873 | 4 | 95 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 11 710 | 77 | −958 | −6 209 | −1 792 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 11 710 | 77 | −958 | −6 209 | −1 792 |
| Net financials | −1 | 2 | 14 995 | 12 025 | 6 032 |
| Profit before tax | 8 793 | 79 | 14 937 | 7 833 | 4 240 |
| Tax | −1 873 | −19 | −0 | −0 | −0 |
| Net profit | 6 920 | 60 | 14 937 | 7 833 | 4 240 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 36 809 | 36 738 | 32 138 | 28 527 | 26 871 |
| Equity | 12 928 | 12 988 | 25 925 | 27 758 | 25 998 |
| Long-term debt | 18 297 | 18 751 | 3 751 | 764 | 873 |
| Short-term debt | 2 667 | 2 082 | 446 | 5 | 1 |
| Total debt | 20 964 | 20 833 | 4 197 | 769 | 874 |
EBITDA margin
-1886.3%
This company
15.8%
Market median
-12039% vs market
20202024
Equity ratio
96.8%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
16.3%
This company
18.4%
Market median
+11% vs market
20202024
Net profit margin
4463.2%
This company
8.1%
Market median
+55001% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CF Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Flexident Holding AB 
Flexident ABBoard members of Flexident Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Fredrik Niring | Chief Auditor | 0 companies |
| Per Lennart Tore Walerud | Board of Directors | 0 companies |
| Robeir Saliba | Chairman | 0 companies |
| Charbel Makdesi | Board of Directors | 0 companies |